Future of Peptide Therapy and Regulation In the next 6-24 months, more physician-led options for peptide access are expected to become available, and it is essential for individuals to have a good relationship with their physician and for physicians to get educated on peptides to ensure safe and effective use 12m0s
A study found that after one year, the average weight loss was higher with tirzepatide: Tirzepatide: 15% Semaglutide: 8% Results can vary based on factors like medication dose, individual response, and the lifestyle changes you make alongside treatment
It may lead to effects like stomach discomfort, acid reflux, bowel irregularities, and convulsions
It will be recommended for use by people with at least one weight-related health condition, as well as those who have a body mass index (BMI) which puts them near the top of the obese range
Otherwise I would have given a higher score